EXHIBIT 99.1

Acquisition of ICG From HCIA to Create Industry's First Comprehensive 
Clinical and Operations Cost Management Solution

SAN RAMON, Calif., April 1 /PRNewswire/ -- MECON, Inc. (Nasdaq: MECN), a 
leading provider of healthcare benchmarking data and cost management tools, 
today announced that it has completed the acquisition of the Implementation 
Consulting Group (ICG) of HCIA, Inc. (Nasdaq: HCIA), formerly known as LBA 
Healthcare, for $7.5 million in cash. ICG, based in Denver, Colorado, is a 
leading provider of benchmarking-based consulting services for clinical 
service lines.

"The two fundamental cost drivers in today's healthcare delivery system are 
clinical efficiency and operational efficiency, both of which must be managed 
while maintaining quality outcomes," stated Vasu Devan, President and Chief 
Executive Officer of MECON. "To date, health care providers have been unable 
to obtain a comprehensive cost management solution that addressed the complete 
clinical and operational environment. This acquisition adds ICG's clinical 
efficiency database and consulting services to MECON's operational cost 
management solution. As a result, MECON's market opportunity has effectively 
doubled. More importantly, we are now positioned to deliver the industry's 
first comprehensive solution for benchmarking-based healthcare cost 
management that encompasses the full spectrum of clinical and operational 
requirements."

ICG's consulting services and data products are designed to lead hospitals 
and physicians to improve their competitive position in clinical service 
lines, with special focus in Cardiology, Pulmonary, Orthopedics, and 
Neurosciences. They help position the hospital as a high-quality/low-cost 
provider with reduced length of stay, decreased



resource utilization, standardized processes of care, improved quality and 
patient satisfaction, and a better foundation for ongoing measurement and 
management of costs and quality.

ICG's proprietary databases serve as a true complement to MECON's flagship 
MECON-PEERnext-TM- Operations Benchmarking Database Service (formerly known 
as MECON-PEERx-TM-), that provides operational efficiency benchmarks to help 
improve the efficiency of the provider infrastructure. "Both companies 
leverage proprietary databases with their consulting services to provide a 
detailed, integrated cost management solution to health care providers," 
noted Devan. "Given our shared business models, ICG constitutes a highly 
complimentary fit with MECON's existing business and strategy."

ICG has been renamed LBA Healthcare and will remain headquartered in Denver. 
Jim Reilly, formerly Vice President of HCIA, has been named Vice President of 
the new LBA Healthcare division at MECON, and will continue to manage its 
group of 33 clinical consulting professionals. He has been joined by Larry 
Byrne, founder and former CEO of the company, who is returning in a strategic 
role to guide the resurgence of the LBA Healthcare division, which is 
currently operating at a $5 million run rate. Devan said, "We are extremely 
pleased to welcome Jim to the MECON team and are especially gratified to be 
able to offer Larry's renowned expertise to the combined organization and our 
expanded customer base."

The acquisition, valued at $7.5 million, is being accounted for as a purchase 
transaction. In conjunction with the transaction, MECON has signed separate 
license agreements with HCIA allowing HCIA's use of LBA Healthcare data and 
MECON's use of HCIA risk adjustment methodologies. MECON expects to record 
one-time acquisition-related charges of up to $1.5 million in the fourth 
quarter of the current fiscal year, ending March 31, 1999. Based on expected 
synergies and current assumptions for the amortization of goodwill, but 
excluding any reduction in goodwill from in-process research and development 
write-offs, the Company expects that the acquisition will be nondilutive to 
FY 2000 earnings per shares.

The MECON-PEERnext Operations Benchmarking Database offers extensive and 
actionable healthcare performance information through instant access to the 
MECON data warehouse via any industry-standard browser. The interactive 
capability of MECON-PEERnext provides an unprecedented ability to create and 
analyze benchmarking reports to customer specifications online for a 
real-time response. MECON customers utilize the data in short and long term 
operational improvement programs to learn from the successes and failures of 
their peers.

MECON, The Benchmarking Solutions Company, brings the first integrated 
clinical and operational solution to healthcare providers who are seeking 
answers to their cost reduction challenges. MECON's family of benchmarking 
data, software products, and advisory services combine to address both the 
clinical and operational arenas where the company finds opportunities for 
improvement, fixes problems, and sustains high levels of performance. The 
Company's customers use the MECON suite of products and services to quantify, 
develop, and implement strategies to reduce costs and improve quality across 
the continuum of care.

Except for the historical financial information contained herein, the 



matters discussed in this news release may be considered "forward-looking" 
statements within the meaning of Section 27A of the Securities Act of 1933, 
as amended, and Section 21E of the Securities Exchange Act of 1934, as 
amended. Such statements include declarations regarding the intent, belief or 
current expectations of the Company and its management. Prospective investors 
are cautioned that any such forward-looking statements are not guarantees of 
future performance and involve a number of risks and uncertainties; actual 
results could differ materially from those indicated by such forward-looking 
statements.  Such risk factors and uncertainties include:

(1)  Dependence on acquiring data from customer systems which may not yet be 
Year 2000 compliant, which could have a material adverse effect on the 
Company's business, operating results and financial condition, if customers 
are incapable or unwilling to submit data. (2) Variability in quarterly 
revenues related to the timing of large consulting engagements. Consulting 
contracts are typically large dollar contracts that represent a material 
percentage of the Company's quarterly revenue. Delays in contract signing 
could result in lower services revenues for the Company, which could have a 
material adverse effect on the Company's business, operating results and 
financial condition, and (3) Non-renewal of older, steeply discounted 
contracts at higher prices due to pricing sensitivity. Termination of 
customer relationships could result in lower subscription revenues for the 
Company, which could have a material adverse effect on the Company's 
business, operating results and financial condition, as well as:

*  Variability of quarterly results and seasonality

*  Dependence on principal products

*  Integrity and reliability of database

*  Competition

*  Dependence on strategic relationships

*  Consolidation and uncertainty in the healthcare industry

*  Potential acquisitions

*  Dependence on key personnel

Such factors also include the risk factors listed from time to time in the 
Company's SEC reports, including but not limited to, the report on Form 
10-KSB for the year ended March 31, 1998, and/or Form 10-QSB for the quarter 
ended December 31, 1998, copies of which are available from the Company's 
Investor Relations Department. The Company assumes no obligation to update the 
forward-looking statements included in this news release.


SOURCE  MECON, Inc.

CONTACT:  media, Eleanor Anderson-Miles, 925-552-6906, or investors, Daylene 
Guidice, 925-552-6915, both for MECON, Inc.


1999, PR Newswire